Page last updated: 2024-08-23

brimonidine tartrate and Carcinoma, Squamous Cell

brimonidine tartrate has been researched along with Carcinoma, Squamous Cell in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Glud, M; Lerche, CM; Olsen, P; Pinto, FE; Wulf, HC1
Chen, E; Huang, CC; Kwak, YJ; Patel, RA1

Trials

1 trial(s) available for brimonidine tartrate and Carcinoma, Squamous Cell

ArticleYear
Randomized controlled pilot study of the preoperative use of brimonidine 0.33% topical gel for hemostasis in Mohs micrographic surgery.
    Journal of the American Academy of Dermatology, 2017, Volume: 77, Issue:6

    Topics: Administration, Topical; Adrenergic alpha-2 Receptor Agonists; Brimonidine Tartrate; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Gels; Hemostatic Techniques; Humans; Mohs Surgery; Pilot Projects; Preoperative Care; Prospective Studies; Skin Neoplasms

2017

Other Studies

1 other study(ies) available for brimonidine tartrate and Carcinoma, Squamous Cell

ArticleYear
Topical Brimonidine Delays Ultraviolet Radiation-Induced Squamous Cell Carcinoma in Hairless Mice.
    Photochemistry and photobiology, 2022, Volume: 98, Issue:6

    Topics: Animals; Brimonidine Tartrate; Carcinoma, Squamous Cell; Female; Mice; Mice, Hairless; Neoplasms, Radiation-Induced; Skin Neoplasms; Ultraviolet Rays

2022